5篇
您的检索式：作者名="A.MCCULLOUGH"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases显示文摘 | Marc A.Silver AlanMaisel Clyde W.Yancy Peter A.McCullough John C.Burnett Gary S.Francis Mandeep R.Mehra GreggFonarow W. BrianGibler David A.Morrow JuddHollander | 2007 | Congestive Heart Failure2007，，： | 1 |
| 2 | Application of a Cardiac Arrest Score in Patients with Sudden Death and ST Segment Elevation for Triage to Angiography and Intervention显示文摘 | PETER A.MCCULLOUGH RAJATPRAKASH KENNETH J.TOBIN WILLIAM W.O’NEILL RICHARD J.THOMPSON | 2007 | Journal of Interventional Cardiology2007，，4： | 1 |
| 3 | Introduction显示文摘Cardiorenal diseaseThe modern day,worldwide epidemics of obesity and hypertension (HTN) are central drivers of a secondary epidemic of type 2 diabetes with combined chronic kidney disease (CKD)and cardiovascular disease (CVD).1 Approximately half of those with diabetes will develop CKD.2 Conversely,half of all cases of end-stage renal disease (ESRD) are due to diabetic nephropathy.With the aging of the general population and cardiovascular care shifting towards the elderly,an understanding of why decreasing levels of renal function act as a major adverse prognostic factor after a variety of cardiac events is imperative.The heart and kidney are inextricably linked via hemodynamic and neurohumoral function (Fig.1).Considerable evidence shows that CKD accelerates atherosclerosis,myocardial disease,valvular disease,and promotes an array of cardiac arrhythmias. | Peter A.McCullough | 2005 | Journal of Geriatric Cardiology2005，2，3： | 0 |
| 4 | Anemia treatment and left ventricular hypertrophy in non-dialysis chronic kidney disease显示文摘To this day, the target hemoglobin level that minimizes cardiovascular risk in chronic kidney disease (CKD) patients remains unclear. When one examines the many randomized trials of epoetin therapy in aggregate, enhanced quality of life provides the most cogent argument for hemoglobin levels above 110 g/L. It remains unclear whether treatment of anemia improves longevity, or even a surrogate marker (such as left ventricular [LV] mass index), especially when applied at earlier phases of CKD. | Robert N.Foley Peter A.McCullough | 2005 | Journal of Geriatric Cardiology2005，2，4： | 0 |
| 5 | Renal function after renal artery stenting显示文摘Atherosclerotic renal artery stenosis (ARAS), a common clinical finding, is increasing in prevalence as the population ages. ARAS is seen in ~ 7% of persons over 65 years of age1 and in ~ 20% of patients at the time of coronary angiography.2 It is an important cause of chronic kidney disease and may result in 11-14% of cases of end stage renal disease. | George S.Hanzel Mark Downes Peter A.McCullough | 2005 | Journal of Geriatric Cardiology2005，2，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员